Blog

Philadelphia Adtech Startup Sidecar, Backed by $33.5M in Funding, Acquired by New York Competitor

December 14, 2021

Philadelphia advertising technology startup Sidecar has been acquired by New York-based competitor Quartile. The deal closed last week, and the terms were not disclosed. Sidecar will take Quartile’s name, and the company will retain its office at One South Broad in Philadelphia. The acquisition will fold Sidecar’s 180 employees into Quartile, bringing the total headcount […]

Read More

In a Deal That ‘Bodes Well’ for Local Investors, Center City’s Sidecar Has Been Acquired by Quartile

December 14, 2021

Performance marketing company Sidecar, a mainstay in the Philly tech scene since its launch nearly a decade ago, has been acquired by New York-based Quartile, the company announced Monday. Five-year-old ad optimization platform Quartile specializes in ecommerce marketplace sellers, and Sidecar CEO Andre Golsorkhi said that the deal — for which details were not disclosed […]

Read More

Roundtrip Raised a ‘Strategic Investment’ Round to Drive Expansion (and Hiring) Plans

December 9, 2021

On Thursday, on-demand patient ride booking company Roundtrip said it had raised a “strategic investment” round of fundraising from a mix of existing and new investors. The Callowhill-based company makes software that connects ride requests to a group of transportation companies. It’s aimed at transporting patients to non-emergent healthcare appointments via the likes of medical […]

Read More

What is 1Philadelphia? Sylvester Mobley on Building Infrastructure For Racial Equity in Philly Tech

December 9, 2021

“Systemic” is just buzzwordy enough to become meaningless without context. But Sylvester Mobley can offer one stark example of the real-world effects of a systemic issue hindering Philly young people’s futures. After launching the Innovation League, a competition-driven tech skills development initiative, this year, he kept hearing from parents that they didn’t feel comfortable about […]

Read More

Revolutionizing the Manufacture of Medicine and More

December 2, 2021

Making new drugs, vaccines and gene therapy can take up to a decade or longer, and cost hundreds of millions of dollars or more. The process is complex and it requires many steps to go from conception to market. And a new platform from ChromaTan, a startup with roots in Happy Valley, is poised to […]

Read More

Previous Next